The G protein-coupled oestrogen receptor GPER in health and disease: an update

[1]  Michael Schaefer,et al.  Multiplex G Protein–Coupled Receptor Screen Reveals Reliably Acting Agonists and a Gq-Phospholipase C Coupling Mode of GPR30/GPER1 , 2022, Molecular Pharmacology.

[2]  Xiao-wei Ding,et al.  Molecular identification of bulbospinal ON neurons by GPER, which drives pain and morphine tolerance , 2022, The Journal of clinical investigation.

[3]  G. Viglietto,et al.  Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia , 2022, Experimental Hematology & Oncology.

[4]  S. Smaili,et al.  Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells , 2022, Molecular and Cellular Endocrinology.

[5]  F. Safari,et al.  The G-Protein-Coupled Estrogen Receptor Agonist Prevents Cardiac Lipid Accumulation by Stimulating Cardiac Peroxisome Proliferator-Activated Receptor α: A Preclinical Study in Ovariectomized-Diabetic Rat Model , 2022, International journal of endocrinology and metabolism.

[6]  D. McDonnell,et al.  Estrogen receptor signaling in the immune system. , 2022, Endocrine reviews.

[7]  T. Garyantes,et al.  Phase 1b study of the novel first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in combination with pembrolizumab in patients with immune checkpoint inhibitor (ICI)-relapsed and refractory solid malignancies and dose escalation update. , 2022, Journal of Clinical Oncology.

[8]  I. Casaburi,et al.  27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer , 2022, Cancers.

[9]  C. Perou,et al.  Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma. , 2021, The Journal of clinical investigation.

[10]  R. Roesler,et al.  The G protein-coupled estrogen receptor (GPER) regulates recognition and aversively–motivated memory in male rats , 2021, Neurobiology of Learning and Memory.

[11]  B. Olde,et al.  Ligand-Independent G Protein–Coupled Estrogen Receptor/G Protein–Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17β-Estradiol , 2021, Molecular Pharmacology.

[12]  V. Miller,et al.  Improving clinical outcomes through attention to sex and hormones in research , 2021, Nature Reviews Endocrinology.

[13]  J. Schlom,et al.  Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing , 2021, Journal for ImmunoTherapy of Cancer.

[14]  Ji Cao,et al.  Dehydroepiandrosterone alleviates intestinal inflammatory damage via GPR30-mediated Nrf2 activation and NLRP3 inflammasome inhibition in colitis mice. , 2021, Free radical biology & medicine.

[15]  J. McQuade,et al.  Phase 1 trial of a novel, first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in patients with advanced or recurrent treatment-refractory solid malignancies. , 2021 .

[16]  G. Nickenig,et al.  G protein-coupled estrogen receptor GPR30 exerts vasoprotective effects in apolipoprotein E-deficient mice , 2021 .

[17]  Q. Gao,et al.  Eplerenone inhibits oxidized low-density lipoprotein-induced proliferation and migration of vascular smooth muscle cells by downregulating GPER expression. , 2021, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[18]  H. El‐Nezami,et al.  Low dose of zearalenone elevated colon cancer cell growth through G protein-coupled estrogenic receptor , 2021, Scientific Reports.

[19]  S. Wardell,et al.  Next-Generation Endocrine Therapies for Breast Cancer. , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  R. Pepermans,et al.  G Protein-Coupled Estrogen Receptor in Cancer and Stromal Cells: Functions and Novel Therapeutic Perspectives , 2021, Cells.

[21]  A. Salem,et al.  Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors. , 2021, Molecular pharmaceutics.

[22]  R. Mostany,et al.  Alterations in the estrogen receptor profile of cardiovascular tissues during aging , 2021, GeroScience.

[23]  N. Heaton,et al.  GPER1 is required to protect fetal health from maternal inflammation , 2021, Science.

[24]  J. Pollock,et al.  Activation of G Protein-Coupled Estrogen Receptor 1 Ameliorates Proximal Tubular Injury and Proteinuria in Dahl Salt-Sensitive Female Rats. , 2021, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  Yu-Qiu Zhang,et al.  The antidepressant and anxiolytic effect of GPER on translocator protein (TSPO) via protein kinase a (PKA) signaling in menopausal female rats , 2020, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  Z. Li,et al.  Activation of the G Protein–Coupled Estrogen Receptor Prevented the Development of Acute Colitis by Protecting the Crypt Cell , 2020, The Journal of Pharmacology and Experimental Therapeutics.

[27]  Lin Zhou,et al.  G protein‐coupled oestrogen receptor promotes cell growth of non‐small cell lung cancer cells via YAP1/QKI/circNOTCH1/m6A methylated NOTCH1 signalling , 2020, Journal of cellular and molecular medicine.

[28]  Xuejun Gao,et al.  Daidzein stimulates fatty acid-induced fat deposition in C2C12 myoblast cells via the G protein-coupled receptor 30 pathway , 2020, Animal biotechnology.

[29]  Claes Ohlsson,et al.  Issue Information , 2020 .

[30]  D. Pollock,et al.  Functional Interaction of Endothelin Receptors in Mediating Natriuresis Evoked by G Protein–Coupled Estrogen Receptor 1 , 2020, The Journal of Pharmacology and Experimental Therapeutics.

[31]  M. Khaksari,et al.  E2-BSA and G1 exert neuroprotective effects and improve behavioral abnormalities following traumatic brain injury: The role of classic and non-classic estrogen receptors , 2020, Brain Research.

[32]  R. Xu,et al.  Mechanisms of estradiol-induced EGF-like factor expression and oocyte maturation via G protein-coupled estrogen receptor. , 2020, Endocrinology.

[33]  Dongfeng Chen,et al.  MiR-155-Mediated Deregulation of GPER1 Plays an Important Role in the Gender Differences Related to Inflammatory Bowel Disease , 2020, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[34]  Xiao-wei Ding,et al.  GPER-Deficient Rats Exhibit Lower Serum Corticosterone Level and Increased Anxiety-Like Behavior , 2020, Neural plasticity.

[35]  E. Prossnitz,et al.  A hypertension patient derived induced pluripotent stem cell model demonstrates a role for GPER in hypertension risk and development. , 2020, American journal of physiology. Cell physiology.

[36]  D. DeMeo,et al.  Sex and gender: modifiers of health, disease, and medicine , 2020, The Lancet.

[37]  J. Pollock,et al.  Evidence for G‐Protein–Coupled Estrogen Receptor as a Pronatriuretic Factor , 2020, Journal of the American Heart Association.

[38]  B. Stanger,et al.  Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma , 2020, Cellular and molecular gastroenterology and hepatology.

[39]  E. Prossnitz,et al.  GPER Contributes to the Development of Pulmonary Hypertension in Female Rats , 2020, The FASEB Journal.

[40]  C. Sobey,et al.  Aldosterone-Induced Hypertension is Sex-Dependent, Mediated by T Cells and Sensitive to GPER Activation. , 2020, Cardiovascular research.

[41]  Helen H Wang,et al.  A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice , 2020, Journal of Lipid Research.

[42]  M. Barton,et al.  Heart Failure With Preserved Ejection Fraction in Women , 2020, JACC. Basic to translational science.

[43]  P. Portincasa,et al.  Activation of Estrogen Receptor G Protein–Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice , 2020, Hepatology.

[44]  H. Tomita,et al.  GPR30-expressing Gastric Chief Cells do not Dedifferentiate but are Eliminated via PDK-dependent Cell Competition During Development of Metaplasia. , 2020, Gastroenterology.

[45]  W. Arap,et al.  Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes , 2020, Science Translational Medicine.

[46]  Chuanyu Gao,et al.  MicroRNA‐2861 and microRNA‐5115 regulates myocardial ischemia–reperfusion injury through the GPR30/mTOR signaling pathway by binding to GPR30 , 2020, Journal of cellular physiology.

[47]  T. Ignatov,et al.  GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients , 2020, Archives of Gynecology and Obstetrics.

[48]  Shui-bing Liu,et al.  Activation of G protein‐coupled receptor 30 protects neurons by regulating autophagy in astrocytes , 2019, Glia.

[49]  Quanguang Zhang,et al.  G-protein-coupled estrogen receptor activation upregulates interleukin-1 receptor antagonist in the hippocampus after global cerebral ischemia: implications for neuronal self-defense , 2019, Journal of Neuroinflammation.

[50]  R. Rizzuto,et al.  Aldosterone Stimulates Its Biosynthesis Via A Novel GPER Mediated Mechanism. , 2019, The Journal of clinical endocrinology and metabolism.

[51]  E. Wauson,et al.  Regulation of Beta Adrenoceptor-mediated Myocardial Contraction and Calcium Dynamics by the G Protein-coupled Estrogen Receptor 1. , 2019, Biochemical pharmacology.

[52]  Yi Wei,et al.  Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics , 2019, J. Comput. Biol..

[53]  Tudor I. Oprea,et al.  A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling. , 2019, Cell chemical biology.

[54]  Seon-Jin Lee,et al.  G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer , 2019, BMB reports.

[55]  Shui-bing Liu,et al.  Activation of G-protein-coupled receptor 30 protects neurons against excitotoxicity through inhibiting excessive autophagy induced by glutamate. , 2019, ACS chemical neuroscience.

[56]  P. Kimmel,et al.  Sex and the kidneys: current understanding and research opportunities , 2019, Nature Reviews Nephrology.

[57]  D. Mary,et al.  Genistein improves viability, proliferation and mitochondrial function of cardiomyoblasts cultured in physiologic and peroxidative conditions. , 2019, International journal of molecular medicine.

[58]  T. Jin,et al.  The developmental Wnt signaling pathway effector β-catenin/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism , 2019, PLoS biology.

[59]  Yu-feng Yao,et al.  Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF. , 2019, American journal of translational research.

[60]  E. Prossnitz,et al.  Nox1 downregulators: A new class of therapeutics , 2019, Steroids.

[61]  Liang-jie Yuan,et al.  G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP/MPP+-induced dopaminergic neuronal injury , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[62]  W. Krajewska,et al.  G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis , 2019, World journal of gastroenterology.

[63]  John H. Zhang,et al.  Activation of GPR30 with G1 attenuates neuronal apoptosis via src/EGFR/stat3 signaling pathway after subarachnoid hemorrhage in male rats , 2019, Experimental Neurology.

[64]  Yang Zhang,et al.  GPER agonist G1 suppresses neuronal apoptosis mediated by endoplasmic reticulum stress after cerebral ischemia/reperfusion injury , 2019, Neural regeneration research.

[65]  B. Olde,et al.  Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter. , 2019, Journal of the American Society of Nephrology : JASN.

[66]  C. Ferrario,et al.  NLRP3 inhibition improves heart function in GPER knockout mice. , 2019, Biochemical and biophysical research communications.

[67]  W. Krajewska,et al.  G protein-coupled estrogen receptor mediates anti-inflammatory action in Crohn’s disease , 2019, Scientific Reports.

[68]  L. Robison,et al.  Contributions of sex to cerebrovascular function and pathology , 2019, Brain Research.

[69]  L. Zon,et al.  Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes. , 2019, Gastroenterology.

[70]  B. Alexander,et al.  Chronic Estrogen Supplementation Prevents the Increase in Blood Pressure in Female Intrauterine Growth-Restricted Offspring at 12 Months of Age , 2019, Hypertension.

[71]  I. Armando,et al.  Estradiol stimulates cell proliferation via classic estrogen receptor-alpha and G protein-coupled estrogen receptor-1 in human renal tubular epithelial cell primary cultures. , 2019, Biochemical and biophysical research communications.

[72]  Yang Zhang,et al.  G protein-coupled estrogen receptor activation improves contractile and diastolic functions in rat renal interlobular artery to protect against renal ischemia reperfusion injury. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[73]  E. Sato,et al.  17-β-estradiol enhances neutrophil extracellular trap formation by interaction with estrogen membrane receptor. , 2019, Archives of biochemistry and biophysics.

[74]  A. Belfiore,et al.  GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression , 2019, Cells.

[75]  Sheng Zhou,et al.  G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer. , 2019, Oncology research.

[76]  Liyan Wang,et al.  Activation of G protein-coupled estrogen receptor protects intestine from ischemia/reperfusion injury in mice by protecting the crypt cell proliferation. , 2019, Clinical science.

[77]  E. Prossnitz,et al.  GPER activation protects against epithelial barrier disruption by Staphylococcusaureus α-toxin , 2019, Scientific Reports.

[78]  S. Thorpe,et al.  GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment , 2018, EMBO reports.

[79]  E. Chaves-Pozo,et al.  Role of estrogens in fish immunity with special emphasis on GPER1. , 2018, Developmental and comparative immunology.

[80]  T. Ignatov,et al.  G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen , 2018, Breast Cancer Research and Treatment.

[81]  Shondra M. Pruett-Miller,et al.  Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1 , 2018, Hypertension.

[82]  Michael G. Sugiyama,et al.  Estrogen Inhibits LDL (Low-Density Lipoprotein) Transcytosis by Human Coronary Artery Endothelial Cells via GPER (G-Protein–Coupled Estrogen Receptor) and SR-BI (Scavenger Receptor Class B Type 1) , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[83]  M. Khaksari,et al.  Cardioprotective and anti-inflammatory effects of G-protein coupled receptor 30 (GPR30) on postmenopausal type 2 diabetic rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[84]  Patrick Sweeney,et al.  A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth. , 2018, ACS medicinal chemistry letters.

[85]  W. Ye,et al.  Icariin modulates mitochondrial function and apoptosis in high glucose-induced glomerular podocytes through G protein-coupled estrogen receptors , 2018, Molecular and Cellular Endocrinology.

[86]  E. Prossnitz,et al.  Abstract P261: GPER is Required for Age-dependent Albuminuria and Glomerulosclerosis: Evidence for its Role in Podocyte Injury and Mesangial Nox1 Regulation , 2018, Hypertension.

[87]  M. M. Trachez,et al.  Cardioprotection Induced by Activation of GPER in Ovariectomized Rats With Pulmonary Hypertension , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[88]  Hongsheng Wang,et al.  GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells. , 2018, Journal of hazardous materials.

[89]  Li-Ching Chang,et al.  Estradiol mediates relaxation of porcine lower esophageal sphincter , 2018, Steroids.

[90]  W. Zou,et al.  The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation , 2018, Journal of Neuroinflammation.

[91]  A. Musti,et al.  Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT , 2018, International journal of molecular sciences.

[92]  L. Eckel,et al.  Selective activation of estrogen receptors, ERα and GPER-1, rapidly decreases food intake in female rats , 2018, Hormones and Behavior.

[93]  M. Delp,et al.  The G protein–coupled estrogen receptor agonist, G‐1, attenuates BK channel activation in cerebral arterial smooth muscle cells , 2018, Pharmacology research & perspectives.

[94]  Wen-fang Chen,et al.  G protein-coupled estrogen receptor is involved in the anti-inflammatory effects of genistein in microglia. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[95]  F. Villarreal,et al.  (‐)‐Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G‐protein coupled estrogen receptor , 2018, European journal of pharmacology.

[96]  K. Takano,et al.  S-Equol, a Major Isoflavone from Soybean, Inhibits Nitric Oxide Production in Lipopolysaccharide-Stimulated Rat Astrocytes Partially via the GPR30-Mediated Pathway , 2018, International journal of inflammation.

[97]  A. P. Alves,et al.  Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER. , 2018, American journal of physiology. Cell physiology.

[98]  M. Wehling.  Rapid actions of aldosterone revisited: Receptors in the limelight , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[99]  E. Prossnitz,et al.  Role of GPER in estrogen-dependent nitric oxide formation and vasodilation , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[100]  E. Prossnitz,et al.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[101]  M. Barton,et al.  GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseases , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[102]  C. Heaps,et al.  The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries , 2018, PloS one.

[103]  K. Smalley.  Why do women with melanoma do better than men? , 2018, eLife.

[104]  Junqian Zhang,et al.  Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade , 2018, eLife.

[105]  D. Kusewitt,et al.  Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin , 2018, The Journal of Immunology.

[106]  M. Pellegrino,et al.  GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer , 2017, Oncotarget.

[107]  J. Custódio,et al.  The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells. , 2017, Chemico-biological interactions.

[108]  Xiao-wei Ding,et al.  Stress-related arterial hypertension in Gper-deficient rats. , 2017, Sheng li xue bao : [Acta physiologica Sinica].

[109]  J. Bopassa,et al.  Activation of G protein‐coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy , 2017 .

[110]  P. Foster,et al.  Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER , 2017, The Journal of clinical endocrinology and metabolism.

[111]  R. Poulsom,et al.  GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions , 2017, Oncotarget.

[112]  V. Lemos,et al.  GPER agonist dilates mesenteric arteries via PI3K‐Akt‐eNOS and potassium channels in both sexes , 2017, Life sciences.

[113]  Beibei Yang,et al.  GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease , 2017, Neuroimmunomodulation.

[114]  W. Krajewska,et al.  Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome , 2017, Molecular and Cellular Endocrinology.

[115]  E. Prossnitz,et al.  GPER Mediates Functional Endothelial Aging in Renal Arteries , 2017, Pharmacology.

[116]  A. Vandenbark,et al.  Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogen , 2017, Metabolic Brain Disease.

[117]  J. Fichna,et al.  G protein‐coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[118]  F. Cirillo,et al.  Protective Role of GPER Agonist G‐1 on Cardiotoxicity Induced by Doxorubicin , 2017, Journal of cellular physiology.

[119]  M. Maggiolini,et al.  A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells , 2017, Oncotarget.

[120]  C. Heaps,et al.  Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA , 2017, PloS one.

[121]  W. Krajewska,et al.  G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study. , 2017, Journal of gastrointestinal and liver diseases : JGLD.

[122]  G. Chen,et al.  GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells , 2017, Molecular and Cellular Endocrinology.

[123]  G. Zapata-Sudo,et al.  Effect of Age, Estrogen Status, and Late-Life GPER Activation on Cardiac Structure and Function in the Fischer344×Brown Norway Female Rat , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[124]  Yan Tang,et al.  G protein-coupled estrogen receptor enhances melanogenesis via cAMP-protein kinase (PKA) by upregulating microphthalmia-related transcription factor-tyrosinase in melanoma , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[125]  P. Thomas,et al.  Additive effects of low concentrations of estradiol-17β and progesterone on nitric oxide production by human vascular endothelial cells through shared signaling pathways , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[126]  Zhiqiang Li,et al.  Activation of G-protein coupled estrogen receptor 1 improves early-onset cognitive impairment via PI3K/Akt pathway in rats with traumatic brain injury. , 2017, Biochemical and biophysical research communications.

[127]  J. Meseguer,et al.  G Protein-Coupled Estrogen Receptor 1 Regulates Human Neutrophil Functions , 2017, Biomedicine Hub.

[128]  G. Zapata-Sudo,et al.  Activation of GPER ameliorates experimental pulmonary hypertension in male rats , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[129]  Qi Zhang,et al.  G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis. , 2016, Cancer letters.

[130]  R. Divella,et al.  Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation , 2016, Journal of Cancer.

[131]  E. Prossnitz,et al.  Obligatory role for GPER in cardiovascular aging and disease , 2016, Science Signaling.

[132]  S. Klein,et al.  Sex differences in immune responses , 2016, Nature Reviews Immunology.

[133]  G. Gao,et al.  Activation of G protein-coupled estrogen receptor 1 (GPER-1) ameliorates blood-brain barrier permeability after global cerebral ischemia in ovariectomized rats. , 2016, Biochemical and biophysical research communications.

[134]  E. Prossnitz,et al.  GPER is required for the age-dependent upregulation of the myocardial endothelin system. , 2016, Life sciences.

[135]  Y. Kirino,et al.  Ameliorative effect of membrane-associated estrogen receptor G protein coupled receptor 30 activation on object recognition memory in mouse models of Alzheimer's disease. , 2016, Journal of pharmacological sciences.

[136]  H. Liu,et al.  Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF‐κB signals , 2016, Molecular oncology.

[137]  B. Katzenellenbogen,et al.  Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues , 2016, Science Signaling.

[138]  J. Winkler,et al.  Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors , 2016, eLife.

[139]  P. De Marco,et al.  GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response , 2016, Scientific Reports.

[140]  A. Kurt,et al.  The protective role of G protein-coupled estrogen receptor 1 (GPER-1) on methotrexate-induced nephrotoxicity in human renal epithelium cells , 2016, Renal failure.

[141]  J. Xu,et al.  G protein‐coupled estrogen receptor is involved in modulating colonic motor function via nitric oxide release in C57BL/6 female mice , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[142]  V. Pelekanou,et al.  Estrogen anti‐inflammatory activity on human monocytes is mediated through cross‐talk between estrogen receptor ERα36 and GPR30/GPER1 , 2016, Journal of leukocyte biology.

[143]  Salil Sharma,et al.  Rescue of Pressure Overload‐Induced Heart Failure by Estrogen Therapy , 2016, Journal of the American Heart Association.

[144]  E. Filardo,et al.  The G-protein coupled estrogen receptor, GPER: The inside and inside-out story , 2015, Molecular and Cellular Endocrinology.

[145]  B. Bussolati,et al.  GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells , 2015, Oncotarget.

[146]  M. Maggiolini,et al.  Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway , 2015, PloS one.

[147]  E. Prossnitz,et al.  Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER , 2015, BMC Cancer.

[148]  J. Correa-Basurto,et al.  The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER). , 2015, Pharmacological research.

[149]  E. Prossnitz,et al.  G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. , 2015, The Journal of endocrinology.

[150]  B. Olde,et al.  G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion , 2015, PloS one.

[151]  E. Prossnitz,et al.  What have we learned about GPER function in physiology and disease from knockout mice? , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[152]  E. Prossnitz,et al.  Abstract P607: Deletion of GPER Protects from Age-related Renovascular Dysfunction and Tubulo-interstitial Injury , 2015, Hypertension.

[153]  P. Portincasa,et al.  Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice , 2015, Journal of Lipid Research.

[154]  M. Barton,et al.  Nicolaus Copernicus and the rapid vascular responses to aldosterone , 2015, Trends in Endocrinology & Metabolism.

[155]  M. Morissette,et al.  Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1 , 2015, Neuropharmacology.

[156]  Eric R. Prossnitz,et al.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein–Coupled Estrogen Receptor and Its Pharmacologic Modulators , 2015, Pharmacological Reviews.

[157]  Shusen Zheng,et al.  G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30. , 2015, American journal of translational research.

[158]  C. Klinge,et al.  Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells* , 2015, The Journal of Biological Chemistry.

[159]  Y. Xiong,et al.  Estrogen regulates Hippo signaling via GPER in breast cancer. , 2015, The Journal of clinical investigation.

[160]  Zong-fang Li,et al.  GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner. , 2015, Oncology reports.

[161]  M. Hirokawa,et al.  G-Protein-Coupled Estrogen Receptor Agonist Suppresses Airway Inflammation in a Mouse Model of Asthma through IL-10 , 2015, PloS one.

[162]  P. Thomas,et al.  The Catecholestrogen, 2-Hydroxyestradiol-17beta, Acts as a G Protein-Coupled Estrogen Receptor 1 (GPER/GPR30) Antagonist to Promote the Resumption of Meiosis in Zebrafish Oocytes1 , 2015, Biology of reproduction.

[163]  R. Hegele,et al.  G-Protein Estrogen Receptor as a Regulator of Low-Density Lipoprotein Cholesterol Metabolism: Cellular and Population Genetic Studies , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[164]  E. Prossnitz,et al.  Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis , 2015, Scientific Reports.

[165]  R. Hegele,et al.  A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women. , 2014, British journal of clinical pharmacology.

[166]  R. Vessella,et al.  Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer. , 2014, Endocrine-related cancer.

[167]  J. Katzenellenbogen,et al.  Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential , 2014, Steroids.

[168]  E. Prossnitz,et al.  G Protein–Coupled Estrogen Receptor Regulates Mammary Tumorigenesis and Metastasis , 2014, Molecular Cancer Research.

[169]  Yoshiki Kobayashi,et al.  Expression and functional roles of G-protein-coupled estrogen receptor (GPER) in human eosinophils. , 2014, Immunology letters.

[170]  F. Naftolin,et al.  The Women's Health Initiative trial and related studies: 10 years later: A clinician's view , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[171]  S. Fuqua,et al.  Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth , 2014, Breast Cancer Research and Treatment.

[172]  M. Pellegrino,et al.  GPER mediates activation of HIF1α/VEGF signaling by estrogens. , 2014, Cancer research.

[173]  D. Clegg,et al.  Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis , 2014, Hormones and Behavior.

[174]  T. Simoncini,et al.  Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women. , 2014, Maturitas.

[175]  U. Kintscher,et al.  Sex- and age-dependent effects of Gpr30 genetic deletion on the metabolic and cardiovascular profiles of diet-induced obese mice. , 2014, Gene.

[176]  Quanguang Zhang,et al.  GPR30 mediates estrogen rapid signaling and neuroprotection , 2014, Molecular and Cellular Endocrinology.

[177]  Lei Dong,et al.  Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance. , 2014, International journal of clinical and experimental pathology.

[178]  E. Prossnitz,et al.  GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast , 2014, Hormones and Cancer.

[179]  M. Larocca,et al.  G‐protein‐coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß‐d‐glucuronide‐induced cholestasis , 2014, Hepatology.

[180]  M. Chappell,et al.  Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling , 2014, Steroids.

[181]  C. Rosano,et al.  Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. , 2014, Molecular nutrition & food research.

[182]  M. Hixon,et al.  Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone , 2014, Molecular and Cellular Endocrinology.

[183]  Manran Liu,et al.  GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts , 2014, Endocrine-related cancer.

[184]  V. Karamyan,et al.  2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. , 2014, European journal of pharmacology.

[185]  G. Neigh,et al.  Estradiol activates epithelial sodium channels in rat alveolar cells through the G protein-coupled estrogen receptor. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[186]  Louis Bodmer.  ACKNOWLEDGEMENTS , 2013, Journal of Biosciences.

[187]  Zhenhua Li,et al.  GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer , 2013, Breast Cancer Research.

[188]  E. Prossnitz,et al.  G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth , 2013, Obstetrics and gynecology international.

[189]  E. Prossnitz,et al.  Regulation of Vascular Smooth Muscle Tone by Adipose-Derived Contracting Factor , 2013, PloS one.

[190]  C. Zhang,et al.  Icariin attenuates high glucose‐induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor‐β production and signalling through G protein‐coupled oestrogen receptor 1 , 2013, Clinical and experimental pharmacology & physiology.

[191]  Y. Mei,et al.  Resveratrol inhibits K(v)2.2 currents through the estrogen receptor GPR30-mediated PKC pathway. , 2013, American journal of physiology. Cell physiology.

[192]  E. Prossnitz,et al.  GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. , 2013, Endocrinology.

[193]  Li Yang,et al.  4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells. , 2013, Toxicology.

[194]  Richard E. White,et al.  Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation , 2013, PloS one.

[195]  Ryan L Brunsing,et al.  The G Protein-coupled Estrogen Receptor (GPER) Agonist G-1 Expands the Regulatory T-cell Population Under TH17-polarizing Conditions , 2013, Journal of immunotherapy.

[196]  A. Hevener,et al.  The role of estrogens in control of energy balance and glucose homeostasis. , 2013, Endocrine reviews.

[197]  R. Dacey,et al.  G Protein–Coupled Estrogen Receptor Agonist Improves Cerebral Microvascular Function After Hypoxia/Reoxygenation Injury in Male and Female Rats , 2013, Stroke.

[198]  E. Prossnitz,et al.  GPER regulates endothelin-dependent vascular tone and intracellular calcium. , 2012, Life sciences.

[199]  V. Holcomb,et al.  Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance , 2012, European Journal of Nutrition.

[200]  R. Komers,et al.  Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. , 2012, American journal of physiology. Renal physiology.

[201]  C. Rosano,et al.  Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. , 2012, Current cancer drug targets.

[202]  Hao Wang,et al.  Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. , 2012, Cardiovascular research.

[203]  M. Grafe,et al.  Contribution of GPR30 for 1,25 dihydroxyvitamin D3 protection in EAE , 2012, Metabolic Brain Disease.

[204]  David D. Moore.  A Conversation with Elwood Jensen , 2012 .

[205]  B. Olde,et al.  17β-Estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1. , 2012, American journal of physiology. Renal physiology.

[206]  C. Rosano,et al.  MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells , 2012, Breast Cancer Research.

[207]  Tudor I. Oprea,et al.  Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[208]  Richard E. White,et al.  Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle. , 2011, American journal of physiology. Endocrinology and metabolism.

[209]  M. Chappell,et al.  Estrogen Receptor GPR30 Reduces Oxidative Stress and Proteinuria in the Salt-Sensitive Female mRen2.Lewis Rat , 2011, Hypertension.

[210]  M. Eghbali,et al.  Estrogen rescues preexisting severe pulmonary hypertension in rats. , 2011, American journal of respiratory and critical care medicine.

[211]  H. Carswell,et al.  Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery , 2011, Neuroscience Research.

[212]  Ryan L Brunsing,et al.  Induction of interleukin‐10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G‐1 , 2011, Immunology.

[213]  D. Clegg,et al.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors , 2011, Acta physiologica.

[214]  E. Prossnitz,et al.  The G-protein-coupled estrogen receptor GPER in health and disease , 2011, Nature Reviews Endocrinology.

[215]  E. Prossnitz,et al.  Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. , 2011, Endocrinology.

[216]  A. Roessner,et al.  G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer , 2011, Breast Cancer Research and Treatment.

[217]  R. Kumar,et al.  Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets. , 2011, Endocrinology.

[218]  S. Andò,et al.  The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1α (HIF-1α) in Breast Cancer Cells and Cardiomyocytes* , 2011, The Journal of Biological Chemistry.

[219]  Hao Wang,et al.  Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats , 2010, PloS one.

[220]  I. Marriott,et al.  GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages , 2010, Molecular and Cellular Endocrinology.

[221]  T. Lóránd,et al.  Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens. , 2010, Current medicinal chemistry.

[222]  C. Porto,et al.  Expression and Signaling of G Protein-Coupled Estrogen Receptor 1 (GPER) in Rat Sertoli Cells1 , 2010, Biology of reproduction.

[223]  A. Roessner,et al.  Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells , 2010, Breast Cancer Research and Treatment.

[224]  E. Prossnitz,et al.  Dilation of Epicardial Coronary Arteries by the G Protein-Coupled Estrogen Receptor Agonists G-1 and ICI 182,780 , 2010, Pharmacology.

[225]  M. Maggiolini,et al.  Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.

[226]  A. Salehi,et al.  Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice , 2010, Molecular and Cellular Endocrinology.

[227]  Bing Zhang,et al.  Estradiol and G1 Reduce Infarct Size and Improve Immunosuppression after Experimental Stroke , 2010, The Journal of Immunology.

[228]  S. Ho,et al.  Activation of GPR30 inhibits growth of prostate cancer cells via sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest , 2010, Cell Death and Differentiation.

[229]  Tudor I. Oprea,et al.  The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. , 2010, Cancer research.

[230]  Piero Portincasa,et al.  New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. , 2009, Biochimica et biophysica acta.

[231]  Guide to Receptors and Channels (GRAC), 4th edition , 2009, British journal of pharmacology.

[232]  M. Halks-Miller,et al.  Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis , 2009, Journal of Neuroimmunology.

[233]  N. Joste,et al.  GPR30 predicts poor survival for ovarian cancer. , 2009, Gynecologic oncology.

[234]  E. Jackson,et al.  2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats. , 2009, Vascular pharmacology.

[235]  K. Korach,et al.  Importance of Extranuclear Estrogen Receptor-α and Membrane G Protein–Coupled Estrogen Receptor in Pancreatic Islet Survival , 2009, Diabetes.

[236]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[237]  Tudor I. Oprea,et al.  In vivo Effects of a GPR30 Antagonist , 2009, Nature chemical biology.

[238]  Didier Picard,et al.  Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF , 2009, The EMBO journal.

[239]  A. Vandenbark,et al.  Membrane Estrogen Receptor Regulates Experimental Autoimmune Encephalomyelitis through Up-regulation of Programmed Death 11 , 2009, The Journal of Immunology.

[240]  D. Clegg,et al.  Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. , 2009, Circulation research.

[241]  B. Olde,et al.  Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. , 2009, Endocrinology.

[242]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[243]  Meenakshi Singh,et al.  GPR30: a novel indicator of poor survival for endometrial carcinoma. , 2007, American journal of obstetrics and gynecology.

[244]  P. Thomas,et al.  Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: A potential novel mechanism of endocrine disruption , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[245]  D. Giri,et al.  Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.

[246]  S. Andò,et al.  17β-Estradiol, Genistein, and 4-Hydroxytamoxifen Induce the Proliferation of Thyroid Cancer Cells through the G Protein-Coupled Receptor GPR30 , 2006, Molecular Pharmacology.

[247]  K. Korach,et al.  Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[248]  Tudor I. Oprea,et al.  Virtual and biomolecular screening converge on a selective agonist for GPR30 , 2006, Nature chemical biology.

[249]  S. Andò,et al.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.

[250]  G. Heiss,et al.  The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial , 2006, Diabetologia.

[251]  S. Baek,et al.  Use of PROTACS as molecular probes of angiogenesis. , 2005, Bioorganic & medicinal chemistry letters.

[252]  M. Koster,et al.  The History of DES, Lessons to be Learned , 2005, Pharmacy World and Science.

[253]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[254]  J. Dong,et al.  Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. , 2005, Endocrinology.

[255]  S. Andò,et al.  The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17β-Estradiol and Phytoestrogens in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[256]  Y. Ouchi,et al.  17 beta-estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor. , 2003, Biochemical and biophysical research communications.

[257]  S. Mader,et al.  Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism. , 2003, Cardiovascular research.

[258]  V. Jordan,et al.  The estrogen receptor: a model for molecular medicine. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[259]  V. Jordan,et al.  Tamoxifen: a most unlikely pioneering medicine , 2003, Nature Reviews Drug Discovery.

[260]  P. Suter,et al.  Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. , 2002, European journal of pharmacology.

[261]  B. Katzenellenbogen,et al.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.

[262]  B. Katzenellenbogen,et al.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. , 2000, Journal of medicinal chemistry.

[263]  C. Stratakis,et al.  A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22) , 2000, Journal of medical genetics.

[264]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[265]  M. Hutchinson,et al.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. , 1999, The New England journal of medicine.

[266]  H. Heng,et al.  Discovery of three novel G-protein-coupled receptor genes. , 1998, Genomics.

[267]  J. Ando,et al.  Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. , 1997, Biochemical and biophysical research communications.

[268]  R. Weigel,et al.  Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. , 1997, Genomics.

[269]  D. Steiner,et al.  Molecular cloning and tissue expression of a novel orphan G protein-coupled receptor from rat lung. , 1997, Biochemical and biophysical research communications.

[270]  E. Smeland,et al.  A novel putative G‐protein‐coupled receptor expressed in lung, heart and lymphoid tissue , 1997, FEBS letters.

[271]  P. Gregor,et al.  Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. , 1997, Biochemical and biophysical research communications.

[272]  C. Owman,et al.  Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. , 1996, Biochemical and biophysical research communications.

[273]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[274]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[275]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[276]  P. Chambon,et al.  Cloning of the human estrogen receptor cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[277]  R. Pietras,et al.  Estrogen receptors in uterine plasma membrane. , 1979, Journal of steroid biochemistry.

[278]  V. Jordan,et al.  Tamoxifen as an anti-tumour agent: effect on oestrogen binding. , 1976, The Journal of endocrinology.

[279]  R. Pietras,et al.  Endometrial cell calcium and oestrogen action , 1975, Nature.

[280]  M. Soloff,et al.  Purification of estradiol receptor from rat uterus and blockade of its estrogen-binding function by specific antibody. , 1969, Biochemical and biophysical research communications.

[281]  E. Jensen,et al.  A two-step mechanism for the interaction of estradiol with rat uterus. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[282]  Ernest Henry Starling,et al.  The Croonian Lectures on the Chemical Correlation of the Functions of the Body , 1968 .

[283]  J. Davis,et al.  Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[284]  J. Gorski,et al.  A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[285]  J. Rock,et al.  Effects of certain 19-nor steroids on reproductive processes and fertility. , 1959, Federation proceedings.

[286]  L. Lerner,et al.  A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol. , 1958, Endocrinology.

[287]  S. R. Reynolds,et al.  PERIPHERAL VASCULAR ACTION OF ESTROGEN IN THE HUMAN MALE. , 1939, The Journal of clinical investigation.

[288]  R. F. Dawson,et al.  The pharmacological actions of diethyl‐stilboestrol and other oestrogenic and non‐oestrogenic substances , 1939, The Journal of physiology.

[289]  J. E. Markee.  RHYTHMIC VASCULAR UTERINE CHANGES , 1932 .

[290]  A. Butenandt.  Über „Progynon“ ein krystallisiertes weibliches Sexualhormon , 1929, Naturwissenschaften.

[291]  B. P. Wiesner,et al.  The Ovarian Hormone , 1928, Nature.

[292]  E. A. Doisy,et al.  An Ovarian Hormone: Preliminary Report on Its Localization, Extraction and Partial Purification, and Action in Test Animals , 1923 .

[293]  M. Barton,et al.  Estrogens and Coronary Artery Disease: New Clinical Perspectives. , 2016, Advances in pharmacology.

[294]  E. Jensen,et al.  A conversation with Elwood Jensen. Interview by David D. Moore. , 2012, Annual review of physiology.

[295]  H. Olivier,et al.  The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines. , 2012, Steroids.

[296]  E. Stefani,et al.  A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. , 2010, American journal of physiology. Heart and circulatory physiology.

[297]  Dwight A Vance.  Premarin: the intriguing history of a controverisal drug. , 2007, International journal of pharmaceutical compounding.

[298]  M. Lachat,et al.  Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. , 2007, Hypertension.

[299]  K. Bland,et al.  Estrogen Action Via the G Protein-Coupled Receptor , GPR 30 : Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis , 2001 .

[300]  J. B. Collip,et al.  THE CHEMICAL NATURE OF EMMENIN , 1934 .

[301]  R. Dacey,et al.  Protein – Coupled Estrogen Receptor Agonist Improves Cerebral Microvascular Function After Hypoxia / Reoxygenation Injury in Male and Female Rats , 2022 .